Patients-12 patients with programmable dual chamber permanent pacemakers. Methods-Calf capillary filtration coefficient (using a modified plethysmographic technique) and plasma atrial natriuretic peptide concentrations were measured during atrioventricular synchronous and ventricular pacing. Results-Atrioventricular asynchrony was associated with higher mean (SD) concentrations of atrial natriuretic peptide (231.9 (123.1) v 53*5 (38.8) pg/ml) and an increased mean (SD) calf capillary filtration coefficient (4.2 (1.1) v 3-6 (1.1) ml/min.mm Hg.100 ml x 10-'), but there was no correlation between the magnitude of the change in these variables in individual patients. Conclusions-The peripheral capillary filtration coefficient may change in response to altered central haemodynamics. Atrial natriuretic peptide remains one potential candidate mechanism, but other factors are also likely to be involved.
(Heart 1996;75:509-512) Keywords: capillary filtration; pacing; atrial natriuretic peptide Despite the considerable capacity of the peripheral microcirculation for autoregulation in health there are reasons to believe that such autoregulation may change in the face of cardiac disease, as a consequence of altered central haemodynamics and the associated neurohumoral changes. One potential mediator of change at a microvascular level is atrial natriuretic peptide, which among other effects has been shown to be capable of altering cardiac filling pressures in man at doses that do not modify renal excretory variables or produce vasodilatation. ' It has been suggested that this effect occurs due to enhancement of fluid flux from intravascular to extravascular compartments. This might be caused by modulation of capillary pressure or alteration in capillary hydraulic conductance, with some support for both hypotheses. Atrial Six patients were taking no medication. One each was taking the combined oral contraceptive pill, hormone replacement therapy, warfarin, propafenone, amlodipine, and nifedipine. Medication remained unchanged throughout the study.
No patient had signs or symptoms of heart failure, peripheral vascular disease, diabetes mellitus, or venous insufficiency of the leg.
MEASUREMENT OF CAPILLARY FILTRATION COEFFICIENT
The capillary filtration coefficient was measured by mercury in silastic strain gauge plethysmography at the calf using the technique described by Gamble et al," which examines limb volume changes in response to a series of small pressure increments in an occlusive cuff. This method has several important theoretical advantages over the more conventional single step technique used in many previously described studies, which relies on a series of questionable assumptions. '2 Patients were studied supine. A pressure cuff with multiple air inlets to permit rapid inflation was applied to the thigh above the knee. Calf swelling rate in response to successive increments in cuff pressure was recorded by a mercury in silastic strain gauge linked through a computer based data logging and analysis system. Serial pressure increments of 8-12 mm Hg were applied every 5 min using an air pump equipped with a multiple resistance air bleed. Once ambient venous pressure is exceeded each increase in cuff pressure produces a characteristic response comprising an initial rapid exponential phase reflecting filling of capacitance vessels and a concurrent linear phase due to fluid efflux from the microcirculation. Each study comprised eight to 10 steps (depending on diastolic blood pressure), with a total study duration of 45-60 min.
Use of sequential small pressure steps considerably reduces the (fig 1) ). This assumption constitutes an important source of error when using single pressure step techniques.'2 Furthermore, interventions that alter peripheral microvascular flow (e.g. orthostasis) may alter isovolumetric venous pressure by altering fractional fluid extraction along the capillary and thus local oncotic pressure.'3 Ambient peripheral venous pressure was estimated by extrapolation of the plot of cuff pressure against asymptotic volume.'3
The mean (SD) intraindividual coefficient of variation in four normal individuals examined four to eight times over nine months was 11-6 (3 4)%.
MEASUREMENT OF ATRIAL NATRIURETIC PEPTIDE
Blood samples for atrial natriuretic peptide assay were drawn into chilled lithium heparin Vacutainers and centrifuged immediately at 4°C. Plasma was separated and stored at -30°C. Samples were analysed in a single batch using the protocol for plasma extraction and radioimmunoassay described by Penney et al.'4 Intra-assay coefficient of variation for this procedure (extraction and radioimmunoassay) derived from replicate control plasmas is 6A4% at a mean plasma atrial natriuretic peptide concentration of 72-7 pg/ml.
STUDY PROTOCOL
Baseline studies were performed without alteration of clinically determined pacemaker variables after 20 min of supine acclimatisation in a temperature controlled laboratory (22 (05)°C). Capillary filtration coefficient was measured as previously described. At the end of this period (typically 75-80 min of supine rest in total) blood was drawn for measurement of atrial natriuretic peptide.
The pacemaker was then reprogrammed to VVI (ventricular) pacing at a rate of 80 beats/min. Some 60-75 min after reprogramming the patient returned to the laboratory and after further acclimatisation the study was repeated. This time interval was chosen because previous work has suggested that plasma levels of atrial natriuretic peptide reach a peak 90-120 min after the onset of atrioventricular asynchrony'5 and it was therefore anticipated that maximal levels of atrial natriuretic peptide would be present during the second measurement of capillary filtration coefficient.
A third similar study was performed between three and 17 days (mean nine) after restoration of the original pacemaker variables. in the capillary filtration coefficient seen in the present study are mediated by atrial natriuretic peptide, but arise through a more complex mechanism in vivo than suggested by in vitro work. For example, it has been suggested that changes in baroreceptor function in patients with mild heart failure may modulate capillary filtration coefficient'8 and atrial natriuretic peptide may in turn influence baroreceptor responses. '9 The relative increase in atrial natriuretic peptide achieved by transition from atrioventricular synchronous to asynchronous pacing in this study is greater than identified in some previous studies.202' This may in part reflect the fact that at baseline the mean atrioventricular interval in the present study approached 175 ms, which has been shown to be associated with lower levels of atrial natriuretic peptide than shorter or longer atrioventricular intervals.22 Further, the relative change in atrial natriuretic peptide on switching from atrioventricular synchronous to asynchronous pacing has been shown to be greater at lower heart rates such as that used in the current study.I°I n summary, this study suggests that acute changes in central haemodynamics can influence microvascular fluid permeability in human peripheral tissues, thereby having the potential to alter the rate of fluid transfer across the microvascular wall. This change is coincident with a substantial change in atrial natriuretic peptide, which in conjunction with previous pharmacological studies adds weight to evidence for a possible physiological role for atrial natriuretic peptide in this context. However, further work is required before this link is established and to define its clinical relevance.
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